Aehr Test Systems 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NASDAQ
Aehr Test Systems announced record quarterly bookings and a $100 million effective backlog, projecting fiscal 2027 revenue between $130 million and $150 million.
NASDAQ
Aehr Test Systems has successfully completed its at-the-market equity offering program, raising $60 million in gross proceeds.
NASDAQ
AEHR Test Systems has entered into an equity distribution agreement to offer and sell up to $60 million of its common stock through William Blair & Company, L.L.C. and Craig-Hallum Capital Group LLC.
NASDAQ
Aehr Test Systems reported strong Q3 FY26 bookings of $37.2 million, driven by AI and data center demand, despite a dip in net revenue to $10.3 million.
NASDAQ
Aehr Test Systems reported softer Q2 FY26 revenue but reinstated fiscal 2026 guidance, citing improved visibility from AI processor and data center semiconductor test and burn-in systems.
NASDAQ
Aehr Test Systems stockholders approved amendments to the 2006 Employee Stock Purchase Plan and the 2023 Equity Incentive Plan, increasing share limits for employee and equity awards.
NASDAQ
Aehr Test Systems shareholders approved all six director nominees, two equity incentive plan amendments, and ratified their independent auditor at the recent Annual Meeting.
NASDAQ
Aehr Test Systems reported fiscal Q1 2026 financial results, exceeding street consensus estimates despite a year-over-year revenue decline, driven by strong AI and data center-related semiconductor test activity.
NASDAQ
Aehr Test Systems announced a substantial decline in fiscal 2025 revenue and net income, reporting a GAAP net loss of $(3.9) million, while simultaneously highlighting strategic expansion into high-growth markets like AI, Gallium Nitride, and silicon photonics.
NASDAQ
Aehr Test Systems announces revenue growth and strong bookings for Q3 2025, but withdraws full-year guidance due to tariff uncertainty.
NASDAQ
Aehr Test Systems' Board of Directors has approved and adopted amended and restated bylaws, including advance notice provisions for director nominations and other business proposals at stockholder meetings.
NASDAQ
Aehr Test Systems announced its second quarter fiscal 2025 results, showing a decrease in revenue and a net loss, but highlighted significant progress in diversifying into new markets like AI and GaN.
NASDAQ
Aehr Test Systems held its annual shareholder meeting on October 21, 2024, where directors were elected, the auditor was ratified, and executive compensation was approved.
NASDAQ
Aehr Test Systems announced its fiscal 2025 first quarter results, showing a decrease in revenue and net income compared to the previous year, but reaffirmed its full-year guidance.
NASDAQ
Aehr Test Systems has entered into new Change in Control and Severance Agreements with its executive officers, providing enhanced benefits upon qualifying terminations.
NASDAQ
Aehr Test Systems has completed its acquisition of Incal Technology for a total of $21 million, consisting of cash and stock.
NASDAQ
Aehr Test Systems announced record full-year revenue and net income, driven by silicon carbide demand, and provided a positive outlook for fiscal year 2025.
NASDAQ
Aehr Test Systems is set to acquire Incal Technology for $21 million, aiming to expand its market presence in the rapidly growing AI semiconductor testing sector.
NASDAQ
Aehr Test Systems announced preliminary fiscal year 2024 results, exceeding previous guidance with record revenue and net income, despite some customer pushouts.
NASDAQ
Aehr Test Systems released an updated corporate presentation on its website, providing investors with the latest company information.
NASDAQ
Aehr Test Systems announced its third quarter fiscal 2024 results, showing a decrease in revenue compared to the previous year but reaffirming its full-year financial guidance.